Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.

It has developed a process that uses nano-particles that are extraordinarily abundant in blood and carry information about their parent cell – known as extracellular vesicles, or EVs – to detect stage I cancer.